scholarly article | Q13442814 |
P50 | author | Janene Pierce | Q124037589 |
P2093 | author name string | Alan O Perantoni | |
Mark P de Caestecker | |||
Andrew J Murphy | |||
Christian de Caestecker | |||
Harold N Lovvorn | |||
James R Anderson | |||
Chase Taylor | |||
P2860 | cites work | The transcriptional activity of CITED1 is regulated by phosphorylation in a cell cycle-dependent manner | Q24297950 |
Wilms' tumorigenesis is altered by misexpression of the transcriptional co-activator, CITED1 | Q24298969 | ||
CITED1 expression in Wilms' tumor and embryonic kidney | Q24337902 | ||
STAT1 activation regulates proliferation and differentiation of renal progenitors | Q24338667 | ||
Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition | Q24685187 | ||
ELR+-CXC chemokines and their receptors in early metanephric development | Q28571457 | ||
Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney | Q28586205 | ||
Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development | Q28592487 | ||
Cited1 and Cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis | Q28593339 | ||
Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network | Q33961864 | ||
Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors | Q34010180 | ||
Wilms' tumor | Q34013130 | ||
Nuclear accumulation of beta-catenin protein indicates activation of wnt signaling in chemically induced rat nephroblastomas | Q34346138 | ||
Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation | Q34428960 | ||
Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene | Q35095712 | ||
Defining and redefining the nephron progenitor population | Q35294035 | ||
Wilms' tumour: connecting tumorigenesis and organ development in the kidney | Q36234726 | ||
Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor | Q36826291 | ||
Fate mapping using Cited1-CreERT2 mice demonstrates that the cap mesenchyme contains self-renewing progenitor cells and gives rise exclusively to nephronic epithelia. | Q37235452 | ||
High-resolution gene expression analysis of the developing mouse kidney defines novel cellular compartments within the nephron progenitor population | Q37356678 | ||
Early organogenesis of the kidney | Q39611879 | ||
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis | Q40262816 | ||
Nuclear accumulation of beta-catenin protein in Wilms' tumours | Q50335613 | ||
Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study | Q69358949 | ||
Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes | Q81243903 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1239-1249 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Journal of Pediatric Surgery | Q15761821 |
P1476 | title | SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor | |
P478 | volume | 47 |
Q37639483 | Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor. |
Q87206471 | Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor |
Q38559338 | Biomarkers to detect Wilms tumors in pediatric patients: where are we now? |
Q37660299 | CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus. |
Q36520712 | CITED1 expression in liver development and hepatoblastoma |
Q34917145 | Cited1 deficiency suppresses intestinal tumorigenesis. |
Q36597449 | Differential regulation of mouse and human nephron progenitors by the Six family of transcriptional regulators |
Q90167841 | Disruption of Robo2-Baiap2 integrated signaling drives cystic disease |
Q64916990 | Expression and clinical significance of p73 in Wilms tumor in children. |
Q36052678 | Genetic and chromosomal alterations in Kenyan Wilms Tumor |
Q37146691 | Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review |
Q34717946 | Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression |
Q55420112 | Modeling Renal Disease "On the Fly". |
Q30449310 | Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa |
Q64120594 | Molecular determinants of WNT9b responsiveness in nephron progenitor cells |
Q35028775 | SIX2 Effects on Wilms Tumor Biology |
Q36297071 | TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination. |
Q92783038 | The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells |
Q38960059 | miR181c promotes apoptosis and suppresses proliferation of metanephric mesenchyme cells by targeting Six2 in vitro. |
Search more.